biOasis Technologies Inc. (BIOAF: OTCQB) | biOasis Provides Further Details Regarding its Agreement with Rising Tide Equity

biOasis Provides Further Details Regarding its Agreement with Rising Tide Equity

Oct 25, 2016

OTC Disclosure News Service

Richmond, BC, Canada

The initial term of this investor relations agreement is until September 30, 2017, which the parties may extend by mutual consent, and either party may terminate the agreement with 30 days written notice. The Company will pay a monthly fee in advance of USD $5,000. Rising Tide will be granted 100,000 incentive share purchase options expiring on October 25th, 2019 exercisable at $1.30. The stock options will vest over 12 months, with 25,000 options vesting on January 25, 2017, 25,000 on April 25, 2017, 25,000 on July 25, 2017 and 25,000 on October 25, 2017. The options follow the guidelines as set out in Company’s stock option plan and as set by TSX Venture Policy. The agreement and options grant and terms are subject to the approval of the TSX Venture Exchange.

Certain statements in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation that may not be based on historical fact, including without limitation statements containing the words “believe”, “may”, “plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”, “expect” and similar expressions. Such forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments express or implied by such forward-looking statements or information. Such factors include, among others, our stage of development, lack of any product revenues, additional capital requirements, risk associated with the completion of clinical trials and obtaining regulatory approval to market our products, the ability to protect our intellectual property, dependence on collaborative partners and the prospects for negotiating additional corporate collaborations or licensing arrangements and their timing. Specifically, certain risks and uncertainties that could cause such actual events or results expressed or implied by such forward-looking statements and information to differ materially from any future events or results expressed or implied by such statements and information include, but are not limited to, the risks and uncertainties that: products that we develop may not succeed in preclinical or clinical trials, or future products in our targeted corporate objectives; our future operating results are uncertain and likely to fluctuate; we may not be able to raise additional capital; we may not be successful in establishing additional corporate collaborations or licensing arrangements; we may not be able to establish marketing and the costs of launching our products may be greater than anticipated; we have no experience in commercial manufacturing; we may face unknown risks related to intellectual property matters; we face increased competition from pharmaceutical and biotechnology companies; and other factors as described in detail in our filings with the Canadian securities regulatory authorities at www.sedar.com. Given these risks and uncertainties, you are cautioned not to place undue reliance on such forward-looking statements and information, which are qualified in their entirety by this cautionary statement. All forward-looking statements and information made herein are based

Copyright © 2016 OTC Markets. All Rights Reserved

The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.

Article source: http://www.otcmarkets.com/stock/BIOAF/news?id=143230

Leave a Reply

WP Facebook Auto Publish Powered By : XYZScripts.com
Bunk Beds